Image 1_Integrated multi-omics analysis and machine learning identify G protein-coupled receptor-related signatures for diagnosis and clinical benefits in soft tissue sarcoma.jpeg

Image 1_Integrated multi-omics analysis and machine learning identify G protein-coupled receptor-related signatures for diagnosis and clinical benefits in soft tissue sarcoma.jpeg

Background<p>G protein-coupled receptors (GPRs) are associated with tumor development and prognosis. However, there were fewer reports of GPR-related signatures (GPRSs) in soft tissue sarcomas (STSs), and we aim to combine GPR-related genes with cellular landscape to construct diagnostic and p...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Duo Wang (1787634) (author)
مؤلفون آخرون:	Jihao Tu (8365032) (author), Jianfeng Liu (122580) (author), Yuting Piao (14118642) (author), Yiming Zhao (348349) (author), Ying Xiong (245379) (author), Jianing Wang (465119) (author), Xiaotian Zheng (6287762) (author), Bin Liu (5899) (author)
منشور في:	2025
الموضوعات:	Genetic Immunology soft tissue sarcoma G protein-coupled receptors machine learning tumor microenvironment personalized therapy
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Table 1_Integrated multi-omics analysis and machine learning identify G protein-coupled receptor-related signatures for diagnosis and clinical benefits in soft tissue sarcoma.xlsx
حسب: Duo Wang (1787634)
منشور في: (2025)

Image 2_Construction of a glycosylation-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in soft tissue sarcoma.jpeg
حسب: Ningning Yuan (4231858)
منشور في: (2025)

Image 1_Construction of a glycosylation-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in soft tissue sarcoma.jpeg
حسب: Ningning Yuan (4231858)
منشور في: (2025)

Image 3_Construction of a glycosylation-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in soft tissue sarcoma.jpeg
حسب: Ningning Yuan (4231858)
منشور في: (2025)

Data for Transcriptomic-based classification identifies prognostic subtypes and therapeutic strategies in soft tissue sarcomas
حسب: Manuel Sokolov Ravasqueira (20372187)
منشور في: (2025)

Characteristics of soft tissue sarcoma.
حسب: Yujin Seo (3094080)
منشور في: (2024)

Figure 1 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Figure 2 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Figure 3 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Figure 4 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Figure 5 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Table 1 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Supplementary Table S1 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Supplementary Table S2 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Supplementary Table S3 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
حسب: Valeriya Pankova (19275494)
منشور في: (2024)

Supplementary Figure S1 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
حسب: David S. Moura (15090375)
منشور في: (2024)

Supplementary Figure S2 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
حسب: David S. Moura (15090375)
منشور في: (2024)

Supplementary Figure S3 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
حسب: David S. Moura (15090375)
منشور في: (2024)

Supplementary Figure S4 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
حسب: David S. Moura (15090375)
منشور في: (2024)

Supplementary Figure S5 from Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial
حسب: David S. Moura (15090375)
منشور في: (2024)

Supplementary Figure 1 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Supplementary Figure 2 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Supplementary Figure 3 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Supplementary Table 1 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Supplementary Table 2 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Supplementary Table 3 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Supplementary Table 4 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Supplementary Table 5 from Optimal Factors That Influence the Establishment of Successful Primary Human Soft-Tissue Sarcoma Cell Lines
حسب: Victoria S. Coward (22246975)
منشور في: (2025)

Table 1_An analysis of the distribution of bone and soft tissue sarcoma diagnoses and their disparities in Southwest Germany: a multicenter approach.docx
حسب: Branko Calukovic (14016459)
منشور في: (2025)

Table 1_Construction of a glycosylation-related prognostic signature for predicting prognosis, tumor microenvironment, and immune response in soft tissue sarcoma.docx
حسب: Ningning Yuan (4231858)
منشور في: (2025)

Increasing Awareness of Soft-Tissue Sarcoma: Podcast of a Patient-HCP Discussion
حسب: Adis journals on behalf of (9646728)
منشور في: (2025)

Data Sheet 1_Establishing preclinical models for clear cell sarcoma of soft tissue.pdf
حسب: Bingbing X. Li (627779)
منشور في: (2025)

Data Sheet 1_AI-assisted peripheral immune profiling reveals unconventional lymphocyte signatures associated with prognosis in soft tissue sarcoma patients.pdf
حسب: Jani Sofia Almeida (5962034)
منشور في: (2025)

Table 1_CD117 (KIT) in canine soft tissue sarcoma: an immunohistochemical and c-kit gene mutation assessment.docx
حسب: Silvia Dell’Aere (18599891)
منشور في: (2025)

Data Sheet 1_Immune monitoring of trabectedin therapy in refractory soft tissue sarcoma patients - the IMMUNYON study.pdf
حسب: Paulo Rodrigues-Santos (3424613)
منشور في: (2025)

Figure S1 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas
حسب: Kimberley S. Samkoe (20877828)
منشور في: (2025)

Figure S2 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas
حسب: Kimberley S. Samkoe (20877828)
منشور في: (2025)

Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas
حسب: Kimberley S. Samkoe (20877828)
منشور في: (2025)

Schematic 1 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas
حسب: Kimberley S. Samkoe (20877828)
منشور في: (2025)

Video 1_Imaging-driven diagnosis of retroperitoneal psoas major alveolar soft part sarcoma: a case report.mp4
حسب: Shasha Wei (1555588)
منشور في: (2025)

Cannot write session to /tmp/vufind_sessions/sess_4lk22b0ib6c9qpmifsguhad2k0